Actively Recruiting
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
Led by Unity Health Toronto · Updated on 2024-12-13
200
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
Sponsors
U
Unity Health Toronto
Lead Sponsor
U
University of Toronto
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about remote mental health monitoring technology for adults with treatment-resistant depression. The main question it aims to answer is: are digital mental health monitoring tools (an electronic data capture platform and wearable device (e.g., smartwatch or smart-ring)) feasible to implement alongside clinical treatment for depression? The secondary aim of this study is to inform preliminary clinical parameters for larger, definitive studies. Participants receiving neuropsychiatric treatment (repetitive transcranial magnetic stimulation, intravenous ketamine, or electroconvulsive therapy) as part of their regular medical care for treatment-resistant depression in the Interventional Psychiatry Program will have their clinical assessment data entered into a digital platform and will wear an accessory-based wearable device for the duration of treatment.
CONDITIONS
Official Title
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (aged 18+) who are capable of giving informed consent
- Patients meeting diagnostic criteria for major depressive disorder (MDD) without psychotic symptoms according to the DSM-5
- Currently experiencing a major depressive episode (MDE)
- Montgomery-Asper Depression Rating Scale (MADRS) score greater than 20 at screening
- Patients meeting criteria for treatment-resistant depression (TRD): failure of 2 or more adequate trials of antidepressant therapy of adequate dose and duration during the current episode
- Enrollment in one of the treatment modalities (rTMS, IVK, or ECT) at the Interventional Psychiatry Program at St. Michael's Hospital, Unity Health Toronto
- Ownership of a smartphone (for participants using wearable devices)
You will not qualify if you...
- Individuals without Internet access (required to access study platforms)
- Medication changes, aside from the treatment received through the IPP, one month (28 days) before screening, or during the entire duration of treatment (variable based on treatment arm)
- Participants who do not speak English fluently enough to successfully communicate study information, answer questions accurately, and/or obtain informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St. Michael's Hospital, Unity Health Toronto
Toronto, Ontario, Canada, M5B 1W8
Actively Recruiting
Research Team
D
Dr. Venkat Bhat, M.D., F.R.C.P.C.
CONTACT
D
Dr. Karisa Parkington, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here